KKR acquired a majority stake in leading Chinese hospital management company, HeTian Hospital Management. Financial terms were not disclosed. Paul Yang, Member and CEO of KKR Greater China, said, "This is a pivotal time for health care in China given the growing demand for quality medical services and treatments nationwide. We’ve seen first-hand some of the issues facing Chinese patients and are dedicated to supporting their needs through the launch of SinoCare and through the platform’s initial investment in HeTian. We are impressed with HeTian’s respected and experienced team of doctors led by Dr. Li, and believe that the company has a unique opportunity to build on its success to deliver excellent care to more Chinese patients.”